Lumosa Therapeutics (Taiwan) Technical Analysis

6535 Stock  TWD 145.00  5.00  0.56%   
As of the 29th of March, Lumosa Therapeutics secures the Mean Deviation of 3.97, downside deviation of 4.62, and Risk Adjusted Performance of 0.2142. Our technical analysis interface lets you check existing technical drivers of Lumosa Therapeutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Lumosa Therapeutics, which can be compared to its peers in the industry. Please verify Lumosa Therapeutics downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Lumosa Therapeutics Co is priced some-what accurately, providing market reflects its recent price of 179.0 per share.

Lumosa Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lumosa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Lumosa
  
Lumosa Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Lumosa Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Lumosa Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lumosa Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Lumosa Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Lumosa Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Lumosa Therapeutics Trend Analysis

Use this graph to draw trend lines for Lumosa Therapeutics Co. You can use it to identify possible trend reversals for Lumosa Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Lumosa Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Lumosa Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Lumosa Therapeutics Co applied against its price change over selected period. The best fit line has a slop of   2.27  , which means Lumosa Therapeutics Co will continue generating value for investors. It has 122 observation points and a regression sum of squares at 194574.99, which is the sum of squared deviations for the predicted Lumosa Therapeutics price change compared to its average price change.

About Lumosa Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lumosa Therapeutics Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lumosa Therapeutics Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lumosa Therapeutics price pattern first instead of the macroeconomic environment surrounding Lumosa Therapeutics. By analyzing Lumosa Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lumosa Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lumosa Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Lumosa Therapeutics March 29, 2024 Technical Indicators

Most technical analysis of Lumosa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lumosa from various momentum indicators to cycle indicators. When you analyze Lumosa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lumosa Therapeutics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Lumosa Stock analysis

When running Lumosa Therapeutics' price analysis, check to measure Lumosa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lumosa Therapeutics is operating at the current time. Most of Lumosa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lumosa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lumosa Therapeutics' price. Additionally, you may evaluate how the addition of Lumosa Therapeutics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets
Please note, there is a significant difference between Lumosa Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lumosa Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lumosa Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.